StockClub

GYRE

GYREGyre Therapeutics, Inc.$ --
Gyre Therapeutics, Inc.

Gyre Therapeutics, Inc.

GYRE

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
23M USD
YoY +2.1%
Operating Income
-9M USD
YoY -511.6%
Net Income
-9M USD
YoY -419.3%
EPS
-0.1$
YoY -433.3%

Revenue

$22.5M
FY2024 Q2$52.4M
$52.4M
Q2
FY2024 Q3$77.9M
$77.9M
Q3
FY2024 Q4$105.8M
$105.8M
Q4
FY2025 Q1$22.1M
$22.1M
Q1
FY2025 Q2$48.8M
$48.8M
Q2
FY2025 Q3$79.4M
$79.4M
Q3
FY2025 Q4$116.6M
$116.6M
Q4
FY2026 Q1$22.5M
$22.5M
Q1
Actual
+$461,000 (+2.1%)

Net Income

$-8.6M
FY2024 Q2$11.1M
$11.1M
Q2
FY2024 Q3$12.2M
$12.2M
Q3
FY2024 Q4$12.1M
$12.1M
Q4
FY2025 Q1$2.7M
$2.7M
Q1
FY2025 Q2$3.1M
$3.1M
Q2
FY2025 Q3$6.8M
$6.8M
Q3
FY2025 Q4$5M
$5M
Q4
FY2026 Q1$-8.6M
$-8.6M
Q1
Actual
$-11.3M (-419.3%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$20.9M
Est:$19M
FY2020BEAT
$20.9M
FY2021BEAT
Actual:$7.3M
Est:$5.1M
FY2021BEAT
$7.3M
FY2022BEAT
Actual:$102.3M
Est:$1M
FY2022BEAT
$102.3M
FY2023IN-LINE
Actual:$113.5M
Est:$113.5M
FY2023IN-LINE
$113.5M
FY2024BEAT
Actual:$105.8M
Est:$101.4M
FY2024BEAT
$105.8M
FY2025BEAT
Actual:$116.6M
Est:$114.8M
FY2025BEAT
$116.6M

Analyst Estimates